HERBAL
MEDICINE
PLANT
LOBELIA
(loe-beel’yuh)
Lobelia inflata L. +(Campanulaceae)
by
RETTODWIKART THENU
LOBELIA
(loe-beel’yuh)
Lobelia inflata L.
+ (Campanulaceae)
SUMMARY AND PHARMACEUTICAL COMMENT
The
principal constituent of lobelia is lobeline, an alkaloid with similar
pharmacological properties to those of nicotine. Lobelia has previously been used
in herbal preparations for the treatment of asthma and bronchitis, and in
anti-smoking preparations aimed to lessen nicotine withdrawal symptoms. However,
in view of its potent alkaloid constituents, excessive use of lobelia and use
during pregnancy and lactation should be avoided.
OTHER COMMON NAMES
Asthma weed, bladderpod, cardinal fl ower,
emetic herb, gagroot, great lobelia, Indian pink, Indian tobacco, pukeweed, rapuntium
inflatum, vomitroot, vomitwort
PHARMACOPOEIAL AND OTHER MONOGRAPHS
BHC 1992(G6)
BHP 1996(G9)
Martindale 35th edition(G85)
LEGAL CATEGORY (LICENSED PRODUCTS)
GSL(G37)
CONSTITUENTS
The
following is compiled from several sources, including General Reference G6.
Alkaloids Piperidine-type.
0.48%. Lobeline (major); others include lobelanine, lobelanidine,
norlobelanine, lelobanidine, norlelobanidine, norlobelanidine and lobinine.
Other constituents Bitter glycoside
(lobelacrin), chelidonic acid, fats, gum, resin and volatile oil.
USES
Lobelia traditionally has been used to treat asthma, bronchitis,
cough, and pneumonia, usually as an expectorant.
INVESTIGATIONAL USES
Researchers are studying lobelia for its cardiac effects
and its antispasmodic effects in the gastrointestinal system. Its use as a smoking
deterrent and treatment for psychostimulant abuse is also under investigation.
FOOD USE
Lobelia
is not generally used as a food.
HERBAL USE
Lobelia
is stated to possess respiratory stimulant, antasthmatic, antispasmodic,
expectorant, and emetic properties. Traditionally, it has been used for
bronchitic asthma, chronic bronchitis, and specifically for spasmodic asthma
with secondary bronchitis. It has also been used topically for myositis and
rheumatic nodules.(G6, G7, G8, G64)
ACTIONS
Lobelia is often used in combination with Capsicum
frutescens (capsicum) and Symphlocarpus
factida (skunk cabbage). Studies have
focused on its use as a smoking deterrent and its emetic, cardiac, and
expectorant properties.
Smoking
Deterrent
Three
of the chemical components of lobelia, lobeline, lobelanine, and lobelanidine, have
properties similar to those of nicotine but generally are considered less
potent. However, toxicity is higher with lobelia than with other traditional
smoking deterrents currently on the market, such as nicotine transdermal
systems (e.g., Nicoderm and Habitrol). The chemical components of lobelia
inhibit smoking by fi rst stimulating nicotine receptors and then inhibiting
them.
Emetic Action
The
emetic action of lobelia results from stimulation of the chemoreceptor trigger zone.
This action is similar to that of other emetics that are available. Lobelia
also activates the vagal and afferent neural pathways responsible for vomiting.
Cardiovascular
Action
Lobelia’s
cardiac action results from both positive inotropic and chronotropic effects.
Blood pressure and the neurotransmitters epinephrine and norepinephrine are
increased in a manner similar to that seen with nicotine usage.
Expectorant
Action
Lobelia
is considered to be a very effective expectorant and has been used to treat respiratory
conditions for many years. It causes bronchodilation.
Other Actions
Lobelia infl ata was found to functionally antagonize the neurochemical
and behavioral effects of the psychostimulants amphetamine and methamphetamine
(Dwoskin et al, 2002; Neugebauer et al, 2007).
ACTIVITIES
Analeptic
(1; PH2); Antiasthmatic (1; CAN; CRC); Anticholinesterase (1; JAD);
Antispasmodic (1; APA; CRC; HHB; PED); Antiviral (f; APA); CNS Stimulant (1; CAN);
Convulsant (f; CRC); Diaphoretic (f; CRC; PNC); Diuretic (1; FNF; MAD; PED);
Emetic (1; APA; CAN; WAM); Euphoric (f; CRC); Expectorant (1; APA; CAN; HHB;
WAM); Laxative (f; PED); Myorelaxant (1; APA; FEL); Nervine (f; CRC; PED);
Respirastimulant (1; CAN; PHR; PH2); Sedative (1; CRC; PED; WAM); Sialagogue
(f; CRC; FEL); Stimulant (f; CRC); Tranquilizer (1; CRC).
Figure 1. Lobelia (Lobelia inflata).
INDICATIONS
Abscess
(f; DEM); Acne (f; JLH); Addiction (1; CRC; PHR); Alcoholism (f; CRC; DEM);
Alopecia (f; CRC); Alzheimer’s (1; JAD); Amenorrhea (f; CRC); Angina (f; CRC; FEL);
Apoplexy (f; FEL); Asphyxia, neonatal (f; MAD); Asthma (1; APA; CAN; CRC; PHR;
PH2); Atony (f; FEL); Bite (f; DEM); Boil (f; PNC); Bronchiectasis (f; MAD);
Bronchosis (1; APA; CAN; CRC; HHB); Bruise (f; APA); Bug Bite (f; APA; PED);
Cancer (f; CRC; JLH); Cancer, breast (f; CRC; JLH); Cardiopathy (f; APA; FEL);
Catarrh (f; CEB; MAD); Chancre (f; DEM); Childbirth (f; CRC); Chorea (f; CRC;
FEL); Cold (f; APA); Colic (f; DEM); Constipation (f; PED); Convulsion (f;
CRC); Cough (1; CRC; FAD; WAM); Cramp (1; APA; CRC; FEL; HHB; MAD; PED); Croup
(f; CRC); Deafness (f; CRC); Debility (f; CRC); Dermatosis (f; HHB); Diarrhea
(f; CRC); Diphtheria (f; CRC); Divination (f; DEM); Dysentery (f; CRC);
Dysmenorrhea (f; CRC; MAD); Dyspepsia (f; CRC; FEL; MAD); Dyspnea (f; MAD);
Dysuria (f; CRC); Earache (f; CRC); Eczema (f; FEL); Emphysema (f; CRC);
Encephalosis (f; MAD); Epilepsy (f; CRC; DEM; MAD); Erysipelas (f; CRC; FEL); Esophagosis
(f; MAD); Faintness (f; CRC); Felon (f; JLH); Fever (f; CRC; FAD; PNC); Flu (f;
APA); Gallstone (f;CRC); Gastrosis (f;
CRC; MAD); Hangover (f; CRC); Hay Fever (f; CRC; HHB); Headache (f; CRC; MAD);
Heart (f; CRC); Hemorrhoid (f; CRC); Hepatosis (f; CRC; MAD); Hernia (f; CEB;
CRC); Hydrophobia (f; CRC); Hyperemesis (f; MAD); Hypertony (f; MAD); Hysteria
(f; CRC); Infection (f; MAD); Inflammation (f; FEL); Insomnia (1; CRC; PED;
WAM); Jaundice (f; CEB; MAD); Laryngosis (1; FEL; PED); Measles (f; CEB);
Meningosis (f; CRC); Morning Sickness (f; CRC); Morphinism (f; CRC); Mucososis
(1; WAM); Myososis (f; PED); Narcosis (f; CRC); Nausea (f; CRC); Nephrosis (f;
CRC); Nervousness (1; CRC; MAD; PED; WAM); Neuralgia (f; CRC; FEL; MAD); Neurasthenia
(f; MAD); Nicotinism (1; CAN; CRC; PHR); Ophthalmia (f; CRC); Pain (1; CRC;
DEM); Palpitation (f; CRC); Periostosis (f; CRC); Peritonosis (f; CRC);
Pertussis (1; APA; CRC; HHB; PED); Phrenosis (f; CRC); Phthisis (f; DEM);
Pleurisy (f; CRC); Pneumonia (f; CRC; FEL; MAD); Poison Ivy (f; APA; CRC; PED);
Psoriasis (f; CRC); Pulmonosis (f; MAD); Respirosis (1; CRC; WAM); Rheumatism
(f; FEL; PED); Ringworm (f; APA); Seborrhea (f; CRC); Shock (f; HHB); Shoulder
(f; CRC); Smoking (1; PH2; PNC); Sore (f; DEM; PNC); Sore Throat (1; FAD; FEL);
Spasm (f; CRC; FEL); Sprain (f; APA); Sting (f; DEM; FEL); Stomatosis (f; HHB);
Tetanus (f; CEB; CRC; FEL); Tonsilosis (f; CRC); Tuberculosis (f; CEB); Typhoid
(f; DEM); Urethrosis (f; CRC); Vaginosis (f; CRC); VD (f; DEM); Vertigo (f;
MAD); Virus (f; APA); Wart (f; HHB; JLH); Water Retention (1; FNF; MAD; PED); Wen
(f; CRC). Not covered by Commission E (KOM).
PRODUCT AVAILABILITY
Capsules, fl uid extract, lozenges, tablets, tincture;
available in combination with cayenne pepper (Capsicum frutescens) and lungwort (Pulmonaria offi cinalis)
Plant Part Used:
Dried leaves
DOSAGES
Smoking
Deterrent
·
Adult PO tablets: the usual
dosage is 2 mg taken with 4 oz water after meals for 6 wk
Other
·
Adult PO dried herb: 0.2-0.6 g
tid
·
Adult PO fl uid extract: 8-10
drops tid (Pizzorno, Murray, 2006)
·
Adult PO tincture: 15-30 drops
tid
Expectorant
·
Adult PO: 100 mg leaf or 0.6-2
ml tincture (Jellin et al, 2008)
DOSAGES
Dosages for oral administration
(adults) for traditional uses recommended in older and contemporary standard
herbal and/or pharmaceutical reference texts are given below.
·
Dried herb 0.2–0.6 g as an infusion or decoction three times daily.(G6,
G7)
·
Liquid extract 0.2–0.6 mL (1 : 1 in 50% alcohol) three times daily.(G6,
G7)
·
Simple Tincture of Lobelia (BPC 1949) 0.6–2.0 mL.
·
Tincture Lobelia Acid 1–4mL (1 : 10 in dilute acetic acid) three
times daily.(G6, G7)
DOSAGES
100
mg leaf as expectorant (AHP); 2–6 tsp fresh leaf (PED); 1–3 g dry leaf (PED); 2
g dry leaf:10 ml alcohol/10 ml water (PED); 0.2–0.6 g herb, or in tea, 3 ×/day
(CAN); 50–600 mg herb/day (HHB); maximum dose 100 mg dry herb up to 3 ×/day
(MAD); 4–10 drops herb 3 ×/day with water or juice (NH); 0.2–0.6 ml liquid herb
extract (1:1 in 50% ethanol) 3 ×/day (CAN); 0.6–2.0 ml herb tincture (BPC)
(CAN); 1–4 ml lobelia tincture (1:10 in dilute acetic acid) (CAN); 10–20 drops
(0.5–1 g) leaf tincture, up to several ×/day (MAD).
Figure 2. Lobelia – dried
drug substance (herb).
PHARMACOLOGICAL ACTIONS
The
pharmacological activity of lobelia can be attributed to the alkaloid
constituents, principally lobeline. Lobeline has peripheral and central effects
similar to those of nicotine, but is less potent. Hence, lobeline initially causes
CNS stimulation followed by respiratory depression. Lobeline is also reported
to possess expectorant properties.
Clinical studies
There
is a lack of clinical research assessing the effects of lobelia and rigorous
randomised controlled clinical trials are required.
SIDE-EFFECTS, TOXICITY
Side-effects
of lobeline and lobelia are similar to those of nicotine and include nausea and
vomiting, diarrhoea, coughing, tremors and dizziness. Symptoms of overdosage
are reported to include profuse diaphoresis, tachycardia, convulsions,
hypothermia, hypotension and coma, and may be fatal.(G45)
CNS: Tremors, dizziness, headache, anxiety, insomnia, seizures
CV: Palpitations, hypotension or hypertension
GI: Nausea, vomiting, anorexia, pain in abdomen, heartburn
INTEG: Hypersensitivity reactions
RESP: Cough, respiratory depression or stimulation
Toxicity: Seizures,
nausea, vomiting, increased salivation, diarrhea, mental confusion, weakness,
change in vision and hearing, respiratory depression, arrhythmias, tremors, hypothermia,
coma, death
CONTRA-INDICATIONS, WARNINGS
The
pharmacological actions of lobeline are similar to those of nicotine. Drug
interactions None documented. However, the potential for preparations of
lobelia to interact with other medicines administered concurrently,
particularly those with similar or opposing effects, should be considered. The
pharmacological activity of lobeline is similar to that of nicotine.
Pregnancy
and lactation Lobelia should not be used during pregnancy or lactation.
Class 2b herb.
Until more research is available, lobelia should not be
used during pregnancy and breastfeeding. It should not be given to children in
large doses as an emetic. Lobelia should not be used by geriatric clients, or
by persons with hepatic/renal disorders, pneumonia, nicotine sensitivity, or
hypersensitivity to it. It should not be used by people who have cardiovascular
disorders such as congestive heart failure, cardiac decompensation, sinus
arrhythmias, valvular dysfunction, bundle branch block, or hypertension.
Toxicity can result from the use of lobelia.
CONTRAINDICATIONS,
INTERACTIONS, AND SIDE EFFECTS
Class
2b, 2d. May cause nausea and vomiting. Cardioactive (AHP; WAM). APA gives it
their negative 5 rating, “definite health hazard to using this substance
internally, even in recommended amounts.” I’d consider the risks of smoking
versus the risk of lobeline and might opt for the lobeline, perhaps first
trying transdermal lobelia plants taped to my arm. I’m not even keen on
transdermal nicotine, but I find it perhaps healthier than smoking, and it
doesn’t affect my neighbors with second-hand smoke. The alkaloid lobeline can
cause cough, diarrhea, dizziness, nausea, tremors, and vomiting (CAN). Overdose
may cause coma, convulsions, diaphoresis, hypotension, hypothermia, tachycardia,
and even fatality. Because of lobeline and its toxicity, its use in pregnancy
and lactation is to be avoided (CAN; WAM). 0.6–1 g leaf is toxic, 4 g fatal
(PHR; PH2).“Health hazards not known with proper therapeutic dosages” (PH2) (but
PH2 designates no specific quantified dosage! JAD).
Interactions
Drug Nicotine: Lobelia increases the effects of nicotine-containing
products; do not use concurrently.
Herb Mayapple: Lobelia may decrease the laxative effect of mayapple.
CLIENT CONSIDERATIONS
Assess
·
Assess the reason the client is
using lobelia.
·
Assess for hypersensitivity
reactions. If present, discontinue the use of lobelia and administer an
antihistamine or other appropriate therapy.
·
Assess for symptoms of
toxicity: seizures, nausea, vomiting, increased salivation, diarrhea, mental
confusion, weakness, change in vision and hearing, respiratory depression,
arrhythmias, tremors, hypothermia, and coma.
·
Assess for the use of
nicotine-containing products and mayapple (see Interactions).
Administer
·
Instruct the client to store
lobelia products in a cool, dry place, away from heat and moisture.
·
Instruct the client to use
lobelia for no more than 6 weeks for smoking cessation.
·
Administer atropine 2 mg subcut
for acute toxicity.
Teach
Client/Family
·
Caution the client not to give
lobelia to children in large doses as an emetic, and not to use in those who
are pregnant or breastfeeding until more research is available.
·
Warn the client to stop smoking
before using lobelia as a smoking deterrent. Nicotine toxicity can occur.
PREPARATIONS
Proprietary
multi-ingredient preparations
UK: Catarrh
Tablets.
REFERENCE
Barnes, J., Anderson,
LA, dan Phillipson, JD 2007. Obat Herbal Edisi
Ketiga. Pers Farmasi. Auckland dan London.
Duke, JA dengan Mary
Jo Bogenschutz-Godwin, Judi duCellier, Peggy-Ann K.
Duke. 2002. Buku Pegangan Obat Herbal 2nd Ed. CRC
Press LLC. AMERIKA SERIKAT.
Linda
S-Roth. 2010. Mosby's Handbook Of Herbal &
Suplemen Alami, Edisi Keempat. Mosby
Elsevier. AMERIKA SERIKAT.
No comments:
Post a Comment